Close Menu

single-cell analysis

COLD SPRING HARBOR, NY (GenomeWeb News) – Through whole-exome sequencing of single cells from a medulloblastoma tumor, researchers were able to identify distinct cancer cell types within the tumor that otherwise may have been overlooked, work presented by Stanford University's Sofia Kyriazopoulou

NEW YORK (GenomeWeb News) – Leerink Swann today downgraded Fluidigm to Market Perform, saying the company "could take a breather in the near term" after a 30 percent spike in its stock since the start of the year.

NEW YORK (GenomeWeb News) – Single-cell technology firm Sphere Fluidics today announced the completion of a $2.5 million investment round.

NEW YORK (GenomeWeb News) – Vanderbilt University is partnering with GE Global Research to evaluate GE's cancer mapping technology for cellular insight into colon tumors.

NEW YORK (GenomeWeb News) –Fluidigm has modified its financing agreement with Bridge Bank, National Association, the South San Francisco, Calif.-based company said in a regulatory filing on Thursday.

Scientists from Arizona State University's Biodesign Institute are using a two-year, approximately $420,000 grant from the National Institutes of Health to further develop a tool that combines laser-based excision and ablation with emulsion-based droplet PCR to profile mRNA expre

NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Wednesday that its third-quarter revenues increased 21 percent year over year driven by strong consumables growth.

A team from the University of Gothenburg working with Life Technologies has published a technique combining reverse transcription and proximity ligation to allow quantitative PCR measurements of the DNA, RNA, and proteins from a single cell.

NEW YORK (GenomeWeb News) – The National Institutes of Health said today that it is using more than $90 million to fund research projects and centers that will accelerate the development of new single cell analysis technologies in a range of fields.

NEW YORK (GenomeWeb News) – Mizuho Securities has initiated coverage of Fluidigm and BG Medicine, placing a Buy rating on both firms.

Pages

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.